| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |